Andere talen Tyra Biosciences, Inc.

Aandelen

TYRA

US90240B1061

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
15,99 ^USD	+3,50%		-6,33%	+15,45%

12/06	Transcript : Tyra Biosciences, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 08:40 AM
13/05	TYRA BIOSCIENCES, INC. : Oppenheimer geeft koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Tyra Biosciences to Present at Upcoming Investor Conferences	23/05
Tyra Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights	09/05
Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of Directors	07/05
Tyra Biosciences, Inc. Announces Board Changes	07/05
Tyra Biosciences Q4 Net Loss Widens	19/03
Tyra Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights	19/03
Tyra Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	19/03
Tyra Biosciences to Present at Upcoming Investor Conferences	27/02
Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthcare Life Sciences Conference	07/02
Tyra Biosciences, Inc. announced that it has received $200.006021 million in funding from RA Capital Management, L.P., Boxer Capital LLC, BVF Partners L.P., Nextech Invest Ltd., OrbiMed Advisors LLC, 5AM Venture Management, LLC	06/02
Sector Update: Health Care Stocks Advance Late Afternoon	02/02
Sector Update: Health Care	02/02
Tyra Biosciences Launches $200 Million Private Placement; Shares Rise	02/02
Top Midday Gainers	02/02
Tyra Biosciences Launches $200 Million Private Placement; Shares Rise	02/02
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing	02/02
Tyra Biosciences Receives FDA Rare Pediatric Disease Designation for Potential Achondroplasia Treatment	02/02
Tyra Biosciences Gets Rare Pediatric Disease Designation For Achondroplasia Therapy	02/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Tyra Biosciences, Inc.

Aandelen

TYRA

US90240B1061

Andere talen

Filters